Nielsen Biosciences Expands CANDIN License With Maruho Co. Ltd
23 Oct 2025 //
BUSINESSWIRE
Nielsen Bio Completes Ph 3 Enrollment For CANDIN In Common Warts
26 Feb 2025 //
BUSINESSWIRE
Nielsen Bio Announces Enrollment of First Patient in Phase 3 Trial of CANDIN
05 Mar 2024 //
BUSINESSWIRE

Market Place
Sourcing Support